In its upcoming report, Kenvue (KVUE) is predicted by Wall Street analysts to post quarterly earnings of $0.25 per share, reflecting a decline of 19.4% compared to the same period last year. Revenues ...
Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson in 2023, finds itself at a critical juncture as it navigates its first full year as an independent entity. The ...
Kenvue (NYSE:KVUE – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on ...
Barclays analyst Lauren Lieberman maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $21.00. The ...
Kenvue Inc. closed 12.96% below its 52-week high of $24.46, which the company reached on November 26th.
Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a consumer health company worldwide. Valued at $39.8 billion by ...
Kenvue Inc. (KVUE), a global consumer health company, is dedicated to delivering trusted personal care, health, and wellness ...